ArticleInternational journal of molecular sciences2026
The Transmembrane Envelope Protein of Porcine Endogenous Retroviruses Modulates Cytokine Release and Gene Expression in Human Immune Cells.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine endogenous retroviruses (PERVs), their transmembrane envelope protein p15E and peptides corresponding to a domain in p15E that is highly conserved among retroviruses, the immunosuppressive (isu) domain, demonstrated immunosuppressive properties. They inhibited in vitro immune reactions, and induced release of IL-6 and IL-10 in human peripheral blood mononuclear cells (PBMCs). We recently showed that p15E of PERV expressed on 293T cells reduced MHC expression, induced cytokine release in co-incubated human PBMCs, and inhibited cytotoxic cells. The cell-surface expression of p15E was chosen to simulate an artificially introduced expression on a transplant. Here, a new construct with a higher expression of p15E and consequently higher effects on cytokine release was designed and used. An intracellular cytokine assay was newly developed and applied, whereas a commercial cytokine array was used to analyze the release of 105 cytokines into the supernatant. The differential gene expression was analyzed by sequencing the RNA of PBMCs incubated with p15E-expressing and wild-type 293T cells. PERV p15E induced an elevated expression of IL-10, IL-6 and 24 other cytokines and modulated the expression of hundreds of genes. Furthermore, coating porcine L23 cells with the synthetic isu peptide of the PERV p15E protein and subsequently co-incubating them with human PBMCs induced IL-10 production, whereas direct addition of the peptide to PBMCs alone did not induce cytokine production. These results demonstrate that the PERV p15E protein can modulate cytokine release by human immune cells and suppress their cytotoxic activity. This immunomodulatory property may have potential applications in protecting transplanted tissues from immune-mediated rejection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.